Author information from the last article
Articles by Heidi Beate Eggesbø
X-linked hypophosphataemia
- Qidi Wang*,
- Cennet Akdeniz*,
- Ansgar Heck,
- Mai Britt Bjørk,
- Ole Rasmus Theisen,
- Heidi Beate Eggesbø,
- Tormod B. Krüger,
- Janne E. Reseland,
- Hege Kampen Pihlstrøm,
- Bjørn Olav Åsvold,
- Guri Grimnes,
- Marianne Aardal Grytaas,
- Silje Hjort Rafaelsen,
- Per M. Thorsby,
- Lena Lande Wekre,
- Trine E. Finnes
28.02.2025:
X-linked hypophosphataemia is a rare genetic disorder that causes renal phosphate wasting, impaired mineralisation of teeth and bones, skeletal deformities and limited mobility, all of which significantly impact on health and quality of life. This clinical review examines the recommendations for...
Downgrading of referrals to breast cancer patient pathway
- Marit Muri Holmen,
- Heidi Beate Eggesbø,
- Kari Kværner,
- Linn Nathalie Støme
08.05.2023:
In order to ensure a standardised process for the investigation and treatment of breast cancer, a patient pathway was introduced in 2015. The aim was to clarify the division of responsibilities between the primary care service and the specialist health service and specify time frames (1), whilst...
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
- Ane Sørlie Kværner,
- Helene Harnæs,
- Dena Helene Alavi,
- Linnea Bärebring,
- Hege Berg Henriksen,
- Marianne Grønlie Guren,
- Peter Mæhre Lauritzen,
- Heidi Beate Eggesbø,
- Gro Wiedswang,
- Sigbjørn Smeland,
- Rune Blomhoff
19.05.2020:
Colorectal cancer is the most prevalent form of cancer among Norwegian men and woman, with 4 428 new cases in 2018 (1). Since the 1940s there has been a doubling of incidence, but also of five-year relative survival, which is now at about 70 % (1). Higher survival is attributed partly to new...